Product Images Zomig

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Zomig NDC 21695-955 by Rebel Distributors Corp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

chemical structure - f2073122 5138 41ba b791 a9b088bb98b7 01

chemical structure - f2073122 5138 41ba b791 a9b088bb98b7 01

figure one graph - f2073122 5138 41ba b791 a9b088bb98b7 02

figure one graph - f2073122 5138 41ba b791 a9b088bb98b7 02

The provided text is a figure caption showing the estimated probability of achieving an initial headache response within 4 hours of initial treatment, for a 5.0 mg nasal spray and a placebo, over a period of up to 20 hours since the initial dose. No further information can be obtained from this text.*

figure two graph - f2073122 5138 41ba b791 a9b088bb98b7 03

figure two graph - f2073122 5138 41ba b791 a9b088bb98b7 03

Figure 2 shows the estimated probability of patients taking an escape medication within 24 hours of the first dosage of the study treatment. The graph depicts the probability for two different treatments, 5.0 mg nasal spray, and placebo. The estimated probability of taking an escape medication is plotted on the Y-axis, and the time in hours since the initial dose is plotted on the X-axis.*

figure 1 - f2073122 5138 41ba b791 a9b088bb98b7 04

figure 1 - f2073122 5138 41ba b791 a9b088bb98b7 04

Not available.*

figure 2 - f2073122 5138 41ba b791 a9b088bb98b7 05

figure 2 - f2073122 5138 41ba b791 a9b088bb98b7 05

figure 3 - f2073122 5138 41ba b791 a9b088bb98b7 06

figure 3 - f2073122 5138 41ba b791 a9b088bb98b7 06

figure 4 - f2073122 5138 41ba b791 a9b088bb98b7 07

figure 4 - f2073122 5138 41ba b791 a9b088bb98b7 07

Zomig 5mg - f2073122 5138 41ba b791 a9b088bb98b7 08

Zomig 5mg - f2073122 5138 41ba b791 a9b088bb98b7 08

This is a description of a medication product with the product ID RZ095506. The medication is a nasal spray device with a total dose of Sraa zormitrptan, manufactured by AstaZeneca UK Limited, located in Macdesfieki, Cheshire, UK, and distributed by Physi. The text also includes information on how to store the medication and keep it out of reach of children.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.